Des Moines, IA, United States of America

Kemin Pharma B.v.b.a.

Calculating rank

USPTO Granted Patents = 5

% Expired Patents = 80.0

Forward Citations = 2

Loading Chart...

11 inventors (with patents filed for the assignee):

Johan Van Der Eycken (5 out of 8 patents)

Johan Van Hemel (5 out of 8 patents)

Jan Vandenkerckhove (5 out of 8 patents)

4. Benedikt J Sas (5 out of 15 patents)

5. Bart Ruttens (4 out of 5 patents)

6. Eric Peys (3 out of 8 patents)

7. Petra Blom (2 out of 3 patents)

8. Johan Neyts (1 out of 29 patents)

9. Jan Balzarini (1 out of 35 patents)

10. Steven Van Hoof (1 out of 2 patents)

11. Eric De Clercq (1 out of 1 patent)

5 patents: Sort by Forward Citations

1. 7534871 - Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity (2009-05-19),

2. 7368475 - Furanose-type bicyclic carbohydrates with biological activity (2008-05-06),

3. 7138531 - Preparation and use of carbohydrate-based bicyclic ring structures with antimicrobial and cytostatic activity (2006-11-21),

4. 7125854 - Bicyclic carbohydrates as antiprotozoal bioactive for the treatment of infections caused by parasites (2006-10-24),

5. 7125853 - [object Object] (2006-10-24),

Company Overview

Kemin Pharma B.v.b.a. is a leading global provider of specialty chemical solutions for the pharmaceutical industry. With a strong focus on research and innovation, Kemin Pharma offers a wide range of high-quality products and services to pharmaceutical companies worldwide. Their advanced technologies and expertise drive value across the entire pharmaceutical supply chain, from drug development to manufacturing and distribution.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

5 Patents

#35 in Des Moines, IA

#311 in Iowa

#51,669 in US

Des Moines, IA, United States of America